Lymphomas Primary Cutaneous

  • W. A. van Vloten


Primary cutaneous T and B cell lymphomas (CTCL and CBCL) are a heterogeneous group of lymphomas with a wide range of clinical manifestations, histology and prognosis. They belong to the group of non-Hodgkin lymphomas. The non-Hodgkin lymphomas are clonal proliferations of lymphoid cells with morphological and membrane properties of different maturation stages of T and B lymphocytes. They were classified according to histologic classification schemes such as the classification of Rappaport, Lukes and Collins, the (updated) Kiel classification and the working Formulation of the WHO, and recently, the Revised European-American Lymphoma (REAL) classification.


Cell Lymphoma Mycosis Fungoides Autologous Bone Marrow Transplantation Sezary Syndrome Cutaneous Lymphoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, de Wolf-Peeters C, Felini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiear E, Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the The International Lymphoma Study Group. Blood 84: 1361–1392PubMedGoogle Scholar
  2. 2.
    Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJLM (1997) EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood 90: 354–371PubMedGoogle Scholar
  3. 3.
    Bunn PA, Lamberg SI (1979) Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treatm Rep 63: 725–728Google Scholar
  4. 4.
    DeVita VT, Hellmann S, Rosenberg SA (1997) Cancer principles and practice of oncology. 5th ed. Lippincott, Philadelphia, pp 334–336Google Scholar
  5. 5.
    Ramsey DL, Lish KM, Yalowitz CB, Soter NA (1992) Ultraviolet-B phototherapy for early stage cutanepous T cell lymphoma. Arch Dermaol 128: 931–933CrossRefGoogle Scholar
  6. 6.
    Herrmann JJ, Roenigh HH, Hurria A, Kuzel TM, Samuelson E, Rademaker AW, Rosen ST (1995) Treatment of mycosis fungoides with photochemotherapy ( PUVA); long term follow-up. J Am Acad Dermatol 33: 234–242Google Scholar
  7. 7.
    Kuzel TM, Roegnik HH, Samuelson E, Herrmann JJ, Hurria A, Rademaker AW, Rosen ST (1995) Effectiveness of interferon alfa-2 combined with phototherapy for mycosis funoides and the Sézary syndrome. J Clin Oncol 13: 257–263PubMedGoogle Scholar
  8. 8.
    Vonderheid EC, Tan E, Kantor AF, Shrager L, Micaily B, van Scott EJ (1989) Long term efficacy, curative potential and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous lymphoma. J Am Acad Dermatol 20: 416–428PubMedCrossRefGoogle Scholar
  9. 9.
    Vloten WA van, Cooijmans ACM, Poel J, Meulenbelt J (1993) Concentrations of nitrogen mustard in the air during topical treatment of patients with mycosis fungoides. Br J Dermatol 128: 404–406CrossRefGoogle Scholar
  10. 10.
    Nielsen M, Rasmussen K, Knudsen N, Thestrup Pedersen K (1994) Long term topical nitrogen mustard does not induce pulmonary fibrosis in MF patients. Acta Derm Venereol 74: 70–71PubMedGoogle Scholar
  11. 11.
    Zackheim HS, Epstein H Jr, Crain W (1990) Topical carmustine (BCNU) for cutaneous T-cell lymphoma: a 15 year experience in 143 patients. J Am Acad Dermatol 22: 802–805PubMedCrossRefGoogle Scholar
  12. 12.
    Hoppe RT, Fuks Z, Bagshaw MA (1979) Radiation therapy in the management of cutaneous T-cell lymphomas. Cancer Treatm Rep 63: 625–632Google Scholar
  13. 13.
    Vloten WA van, de Vroome H, Noordijk E (1985) Total skin electrom beam irradiation for cutaneous T-cell lymphoma (mycosis fungoides). Br J Dermatol 112: 697–702CrossRefGoogle Scholar
  14. 14.
    Beljaards RC, Kaudewitz P, Berti E, Gianotti R, Neumann C, Rosso R, Meijer CJLM, Willemze R (1993) Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favourable prognosis. Cancer 71: 2097–2103PubMedCrossRefGoogle Scholar
  15. 15.
    Vonderheid EC, Saijadian A, Kadin ME (1996) Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30 positive lymphp-proliferative disorders. J Am Acad Dermatol 34: 470–476PubMedCrossRefGoogle Scholar
  16. 16.
    Beljaards R, Meijer CJLM, van der Putte SCI, Hollema H, Geerts ML, Bezemer PD, Willemze R (1994) Primary cutaneous T-cell lymphomas: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungpoides and CD30-positive large cell lymphoma. J Pathol 172: 53–60PubMedCrossRefGoogle Scholar
  17. 17.
    Sigurdsson V, Toonstra J, Hezemans-Boer M, van Vloten WA (1996) Erythroderma: a clinical and follow up study of 102 patients, with emphasis on survival. J Am Acad Dermatol 35: 53–57PubMedCrossRefGoogle Scholar
  18. 18.
    Winkelmann RK, Diaz-Perez JL, Buechner SA (1984) The treatment of Sézary syndrome. J Am Acad Dermatol 10: 1000–1003PubMedCrossRefGoogle Scholar
  19. 19.
    Zackheim HS, Kashani-Sabet M, Hwang ST (1996) Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in 29 patients. J Am Acad Derm 34: 626–631PubMedCrossRefGoogle Scholar
  20. 20.
    Edelson RL, Berger C, Gasparro F, Jegasothy B, Heald P, Wintrobe B (1987) Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 316: 297–303PubMedCrossRefGoogle Scholar
  21. 21.
    Duvic M, Hester JP, Lemak NA (1996) Photopheris therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 35: 573–579PubMedCrossRefGoogle Scholar
  22. 22.
    Taylor A, Gasparro P (1992) Extracorporal photochemotherapy for cutaeous T-cell lymphoma and other diseases. Seminars in Hematology 29: 132–141PubMedGoogle Scholar
  23. 23.
    Zic J, Arzubiaga C, Salhany KE, Parker RA, Wilson D, Stricklin GP, Greer J, King LE (1992) Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 27: 729–736PubMedCrossRefGoogle Scholar
  24. 24.
    Rijlaarsdam JU, Toonstra J, Meijer CJLM, Noordijk EM, Willemze R (1996) Treatment of primary cutaneous B-cell lymphomas of follicular center cell origin. A clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. J Clin Oncol 14: 549–555PubMedGoogle Scholar
  25. 25.
    Rijlaarsdam JU, van der Putte SCJ, Berti E, Kerl H, Rieger E, Toonstra J, Geerts ML, Meijer CJLM, Willemze R (1993) Cutaneous immunocytomas: a clinicopathological study of 26 cases. Histopathology 23: 117–125PubMedCrossRefGoogle Scholar
  26. 26.
    Vermeer MH, Geelen FAMJ, van Haselen ChW, van Voorst Vader PC, Geerts ML, van Vloten WA, Willemze R (1996) Primary cutaneous large B-cell lymphomas of the legs. Arch Dermatol 132: 1304–1308Google Scholar
  27. 27.
    Rijlaarsdam JU, Huygens PL, Beljaards RL, Bakels V, Willemze R (1992) Oral etoposide in the treatment of cutaneous large cell lymphoma. Brit J Dermatol 127: 524–528CrossRefGoogle Scholar
  28. 28.
    Savin A, Piro LD (1993) The newer purine analogs. Significant therapeutic advances in the management of lymphoid malignancies. Cancer 72: 3470–3483Google Scholar
  29. 29.
    Greiner D. Olsen EA, Petroni G (1997) Pentostatin (2’-deoxycoformycin) in the treatment of cutaneus T-cell Lymphoma. J Am Acad Dermatol 36: 950–955PubMedCrossRefGoogle Scholar
  30. 30.
    Foss FM, Ihde DC, Breneman DL, Phelps RB, Fischmann AB, Schechter GP, Linnoila I, Breneman JC, Cotelingam JD, Ghosh BC, Steinberg SM, Lynch JW, Phares JC, Stocker JL, Bastian A, Sausville EA (1992) Phase II study of pentostatine and intermittent high dose recombinant interferon alfa-2a in advanced mycosis fungoides mycosis/Sézary syndrome. J Clin Oncol 10: 1907–1913PubMedGoogle Scholar
  31. 31.
    McDonald CJ, Bertino JR (1978) Treatment of mycosis fungoides lymphoma effectiveness of infusion of methotrexate followed by oral citrovorum factor. Cancer Treatm Rep 62: 1009–1014Google Scholar
  32. 32.
    Schappell DL, Alper JC, McDonald CJ (1995) Treatment of advanced mycosis fungoides and Sézary syndrome with continuous infusions of methotrexate followed by fluorouracil and leucovorin rescue. Arch Dermatol 131: 307–313PubMedCrossRefGoogle Scholar
  33. 33.
    Benchikhi H, Zeitoun Ch, Bagot M, Wechsler J, Vaillant L, Joly P, Revuz J (1996) Syndrome de Sézary traité par cytaphérèses. Ann Dermatol Venereol 123: 247–250PubMedGoogle Scholar
  34. 34.
    Bunn PA, Hoffman SJ, Norris D, Goltitz LE (1994) Systemic therapy of cutaneous T- cell lymphomas ( Mycosis fungoides and the Sézary syndrome ). Ann Intern Med 12: 592–602Google Scholar
  35. 35.
    Molin L, Thomsen K, Volden G, Aronsson A, Hammar H, Hellbe L (1987) Oral retinopids in mycosis fungoides and Sézary syndrome: acomparison of isotretinoin and etritinate. Acta Dermatol Venereol 67: 232–236Google Scholar
  36. 36.
    Cooper DL, Braverman IM, Sarris AH, Durivage HJ, Saidman BH, Davis CA, Hait WN (1993) Cyclosporin treatment of refractory T-cell lymphomas. Cancer 71: 2335–2341PubMedCrossRefGoogle Scholar
  37. 37.
    Marolleau JP, Baccard M, Flageul B, Rybojad M, Laroche L, Vérola O, Brandely M, Morel P, Gisselbrecht C (1995) High-dose recombinant interleukine-2 in advanced cutaneous T-cell lymphoma. Arch Dermatol 131: 574–579PubMedCrossRefGoogle Scholar
  38. 38.
    Saleh MN, LeMaistre CF, Kuzel TM, Foss F, Platanias LC, Schwartz G, Ratain M, Rook A, Freytes CO, Craig F, Reuben J, Sams MW, Nichols JC. Anti-tumor activity of DAB389 IL-2 fusion toxin in cutaneous T-cell lymphoma. In pressGoogle Scholar
  39. 39.
    Bigler RD, Crilley P, Micaily B, Brady LW, Topolsky D, Bulova S, Vonderheid EC, Brodsky I (1991) Autologous bone marrow transplantation for advanced stage mycosis fungoides. Bone marrow Transplant 7: 133–137PubMedGoogle Scholar
  40. 40.
    Zeitoun C, Baccard M, Marolleau JP, Rybojad M, Baruchel A, Moerl P, Brice P (1996) Autogreffe de moelle osseuse dans le traitement des lymphomes cutanés. Ann Dermatol Venereol 123: 79–84PubMedGoogle Scholar
  41. 41.
    Burg G, Klepzig K, Kaudewitz P, Wolff H, Braun-Falco 0 (1986) Acyclovir in lymphomatoid papulosis and mycosis fungoides. JAMA 256: 214–215Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • W. A. van Vloten

There are no affiliations available

Personalised recommendations